Commercial
Have you heard the one about disease awareness?
If you want to engage patients, it’s important to tell a compelling story, contends Dr Emre Basar of Baxter International.
More Access and Evidence Articles
Access and Evidence
Value-added services central to pharma strategy
By 2020 most treatments will be paid for based on accomplished outcomes, meaning that pharma will need to move into the health management space to maximize the effectiveness of their products making “beyond the pill” services a standard, claims eyeforpharma's Value Added Services report.
Access and Evidence
How to create the perfect value proposition
In times of austerity measures, where affordability is more important than value, creating a value proposition the HTAs can’t say no to is critical. Here we explore some tips on how to do that based on a recent eyeforpharma Payer Webinar.
Commercial
Value-Added Services: Stay the course for success
A series of case studies showcasing critical success factors of developing value-added services, shows that long-term investment is the key to getting it right.
Access and Evidence
Bridging the value gap
Formulary Development Pharmacist for NHS England in the Surrey and Sussex Healthcare NHS Trust, Omar Ali talks to Nick de Cent about how pharma companies can navigate the “value” landscape.
Access and Evidence
Six ways to progress mHealth adoption
Michael Morgan-Curran is Global Director of mHealth and Diabetes Programme Director at The GSMA. A long-running advocate for the potential benefits of mobile technology in healthcare, he highlights the need for a unified effort in order for mHealth adoption to grow.
Commercial
mHealth to Transform Healthcare: Can Pharma Compete?
David Doherty is the co-founder of 3G Doctor, a service providing documented mobile video consultations with registered Doctors.
Access and Evidence
It's Time to Go on the Payer Journey
Pharma is still not speaking the language of payers, despite attempts to engage them with "innovation" and value-added services, discovers Nick de Cent.
Access and Evidence
Pfizer Integrated Health: Lessons on rolling out a service
Although the future of pharma might be in services, the industry has to change its culture before it’s ready to move on from selling pills alone.
Commercial
Time to rip up your list of competitors and start again
The results of the 2014 eyeforpharma Healthcheck Survey are in. We analyze the feedback from 1600 global participants, drawing on the insights of key industry insiders on the survey findings.